BDD opens Bio City base after MHRA inspection

The two year project was funded by £2 million from existing investors led by angel investment syndicate, Archangels, Scottish Enterprise and British Business Bank.

Constructed by cleanroom specialists Guardtech Group, the GMP facility significantly expands BDD’s manufacturing capabilities and clinical testing services for small and medium-sized pharmaceutical company R&D.

BDD head of quality Stephen Clarke commented: “This new additional facility provides opportunity to generate even quicker reliable data on the safety and effectiveness of these newly developed medicines. That in turn will lead to new medicines getting into patients quicker and so improve patient health sooner.

“The outcome of the recent UK Government inspection provided a high level of independent confidence that we are doing all the correct things, in the correct way, consistently.”